InvestorsHub Logo
Followers 34
Posts 2490
Boards Moderated 0
Alias Born 02/04/2013

Re: abew4me post# 409669

Monday, 04/03/2023 11:18:53 AM

Monday, April 03, 2023 11:18:53 AM

Post# of 462048
Well if you think about it the $140M we have in the bank is not enough which is why they have the $150M as backup. They will need $40M to $60M for Alz, $20M - $30M for PD, $10M to commercialize Rett, $10M ish for Autism, $10M for the undisclosed trial. To run the company for the next 2 years along with adding employees maybe another $20M - $40M. That pretty much eats up the $140M. Might be on the low side a bit.

The ideal path forward at this point in time would be to partner, go grab $250M - $500M up front for someone to get control of the P3 or P4 Alz trial and the PD trial and we handle the rest. The stock price would go wild and give us some validation. I am not longer in the camp that we get a billion for a partnership. We have not shown enough to warrant that level of commitment.

For those who say they will have rev for Rett to help offset , that is true but that will take over a year to ramp up assuming they get approval by the end of the first quarter of next year and they will have to spend a lot of money prior to they actual selling of the product.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News